A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia
Clinical trial NCT00416169 · COMPLETED
Trial details
- NCT number
- NCT00416169
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-05-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.